Inhibition of the spindle assembly checkpoint kinase Mps-1 as a novel therapeutic strategy in malignant mesothelioma. [electronic resource]
Producer: 20171201Description: 6501-6507 p. digitalISSN:- 1476-5594
- Animals
- Antineoplastic Agents -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Cell Cycle Proteins -- antagonists & inhibitors
- Cell Line, Tumor
- Cell Survival -- drug effects
- Cisplatin -- administration & dosage
- Gene Expression Regulation, Neoplastic -- drug effects
- Humans
- Lung Neoplasms -- drug therapy
- M Phase Cell Cycle Checkpoints -- drug effects
- Mesothelioma -- drug therapy
- Mesothelioma, Malignant
- Mice, Inbred BALB C
- Neoplasms, Experimental -- drug therapy
- Pemetrexed -- administration & dosage
- Protein Kinase Inhibitors -- administration & dosage
- Protein Serine-Threonine Kinases -- antagonists & inhibitors
- Protein-Tyrosine Kinases -- antagonists & inhibitors
- Pyrazoles -- pharmacology
- Pyrimidines -- pharmacology
- Survival Analysis
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.